Join
Live feed
·
INSIDERFilingvia Quantisnow
CinCor Pharma Inc. logo

SEC Form 4: Freeman Mason returned 40,000 shares to the company and sold $91 worth of shares (6 units at $15.21), closing all direct ownership in the company to satisfy withholding tax

ByQuantisnow·Wall Street's wire, on your screen.
CINC· CinCor Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CINC (CinCor Pharma Inc.) and more on Quantisnow.